Sign in
4

Changes in Ownership

CASTLE BIOSCIENCES INC Filed Acc 0001628280-26-022135

Pres. & Chief Exec. Officer sold 4,172 shares at $25.55 ($106,599)

  • Pres. & Chief Exec. Officer acquired 550 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
MAETZOLD DEREK J Pres. & Chief Exec. Officer 2026-03-26 Option exercise 10b5-1 +550 $2.39 $1,315 22,029 D
MAETZOLD DEREK J Pres. & Chief Exec. Officer 2026-03-26 Sale 10b5-1 −550 $25.55 $14,053 21,479 D
MAETZOLD DEREK J Pres. & Chief Exec. Officer 2026-03-26 Sale 10b5-1 −1,357 $25.55 $34,673 50,209 I
MAETZOLD DEREK J Pres. & Chief Exec. Officer 2026-03-26 Sale 10b5-1 −1,153 $25.55 $29,460 42,673 I
MAETZOLD DEREK J Pres. & Chief Exec. Officer 2026-03-26 Sale 10b5-1 −278 $25.55 $7,103 3,058 I
MAETZOLD DEREK J Pres. & Chief Exec. Officer 2026-03-26 Sale 10b5-1 −278 $25.55 $7,103 3,058 I
MAETZOLD DEREK J Pres. & Chief Exec. Officer 2026-03-26 Sale 10b5-1 −278 $25.55 $7,103 3,058 I
MAETZOLD DEREK J Pres. & Chief Exec. Officer 2026-03-26 Sale 10b5-1 −278 $25.55 $7,103 3,058 I
Derivatives
MAETZOLD DEREK J Pres. & Chief Exec. Officer 2026-03-26 Option exercise · Stock option (right to buy) 10b5-1 −550 13,732 D
Open-market sales · 4,172 sh · avg $25.55 · $106,599
Loading xslF345X06/wk-form4_1774909763.xml…